The purpose of this study was to develop a quantitative structure-activity relationship (QSAR) for the prediction of the apparent volume of distribution (Vd) in humans for a heterogeneous series of drugs. The relationship of many computed, and some experimental, structural descriptors with Vd, and the Vd corrected for protein binding (unbound Vd), was investigated. Models were constructed using stepwise regression analysis for all the 70 drugs in the dataset, as well as for acidic drugs and basic drugs separately. The predictive power of the models was assessed using half the chemicals as a test set, and revealed that the models for Vd yielded lower prediction errors than those constructed for the unbound Vd (mean fold error of 2.01 for Vd compared to 2.28 for unbound Vd). Moreover, the separation of the compounds into acids and bases did not reduce the prediction error significantly.
Introduction
Modern drug design focuses not only on the pharmacological activity of a compound but also considers a range of other properties including its pharmacokinetic behaviour.
A successful drug candidate should demonstrate, amongst others, the ability to be absorbed, to reach its site of action and a suitable half-life. In recent years there has been an enormous interest in the prediction of human pharmacokinetic properties using different methods ranging from computational approaches to using in vitro and in vivo data. This is due to the fact that a large proportion of drugs fail in development due to poor absorption, distribution, metabolism and elimination (ADME) properties (Kennedy 1997) . The aim of these studies is to provide screening tools for drugs at a very early stage of development. Animal pharmacokinetic studies are a routine tool to predict drug behaviour in man. Furthermore, human-derived cellular or subcellular systems have been developed to measure permeation, membrane transport, absorption, distribution, metabolism and excretion; the systems as summarised by Balant and Gex-Fabry (2001) include partition coefficients, caco-2 cell monolayers, plasma protein binding, microsomes, hepatocytes and enzyme systems. QSAR methods provide models not only for prediction of pharmacological activity but also for toxicological endpoints, 
The second volume term is the volume of distribution at steady state (V ss ) which represents the volume in which a drug would appear to be distributed during steady state if the drug existed throughout that volume at the same concentration as that in the measured fluid (plasma or blood). When using pharmacokinetics to make drug dosing decisions, the differences between V area and V ss are not usually clinically significant 
Materials and Methods

Pharmacokinetic Data
Data for the volume of distribution at steady state (Vd) and the plasma protein binding (ppb) of 70 drugs, belonging to different chemical groups, were collected from the literature (Perry 2002; Moffat et al 1986; Lam et al 1997; Durnas et al.1990; Schoerlin et al 1990; Fulton & Sorkin 1995; Ritschel & Hammer 1980; Ritschel et al 1995; Raaflaub & Speiser-Courvoisier 1974; Glare & Walsh 1991; Thummel & Shen 2001; Sonne et al 1988; Greenblatt 1981; Potter & Hollister, 2001) . Where several Vd values were available for a compound, the mean was used in the analyses. The volume of distribution of free drug, Vdu = Vd/(1-ppb), was also used for the development of predictive models. The compounds and the pharmacokinetic data are listed in Table 1 together with the relevant references.
Physicochemical and structural properties
A total of 75 structural descriptors for these compounds were obtained from various software packages. others, log P and log D at pH 1 and 7.4. The fraction of the unionised form of drugs and log D at pH 7.4 were also calculated from experimental pK a (pK a(Exp) ) taken from the references (see Table 3 ) and log P* values taken from the Biobyte database by following the formulae below. Note that as the aim was calculation of the unionised fraction of drugs, only the first acidic pK a and the first basic pK a were considered.
For weak bases: fiB = 100/(1+antilog (7.4 -pK a(Exp) ))
log D 7.4calc =log P* + log (1+antilog (7.4-pK a(Exp) )) (4) For weak acids: fiA= 100/(1+antilog (pK a(Exp) -7.4))
log D 7.4calc = log P* + log (1+antilog (pK a(Exp) -7.4)) (6) fu calc =100-(fiA+fiB)
In equations (3-7), fiB, fiA, fu calc are, respectively, percents of cationic, anionic and unionised drug at pH=7.4.
Development of QSARs
Stepwise regression analysis was used to determine statistically significant relationships between structural parameters and the volume of distribution. The statistical analyses were performed using the MINITAB (release 13.1) statistical software. In order to avoid the risk of chance correlations, loss of interpretability and predictability, the number of parameters in the models was kept as low as possible. Accordingly, the stepwise was cut short when addition of the third or fourth parameter did not add to the interpretability and predictability of the models. QSARs were sought for the whole dataset and also for the acidic and basic drugs separately. A compound was allocated to the acidic group of drugs if the percent ionised as an acid (anionic percent, fiA), was higher than the percent ionised as a base (cationic percent, fiB) at pH 7.4 and was allocated to the basic group if fiB was higher than fiA. While deletion of outliers often improves the statistics of a QSAR, it was decided to keep all the compounds in the study, unless they affected the coefficients of equations significantly.
In order to test the predictive power of the models, the data sets were divided into the two equal groups, a training set and test set. To this end, the data were ranked based on the ascending Vd values and every other compound was allocated in the test set and the remaining compounds were assigned into the training set. Stepwise regression on the training set often led to the models containing parameters other than those involved in the models for the whole dataset. Therefore, for simplicity, multiple regression analysis was performed on the training set using the parameters obtained from the previous The following statistical details of the models were noted: n the number of observations, r the correlation coefficient, s the standard deviation, F the Fisher statistic and the p value. The figures in parentheses with the regression coefficients were standard errors of coefficients.
Results
The apparent volume of distribution (Vd) and the extent of protein binding for the compounds used in this study are listed in Table 1 together with the relevant references.
Data were obtained for a wide range of drug substances. These include central nervous system agents and other drugs, such as benzodiazepines, barbiturates, hydantoins, succinimides, morphine and related analgesics, tricyclic antidepressants, phenothiazine derivatives, butyrophenones, anaesthetics, non-steroidal anti-inflammatory drugs and so on. The Vd values cover a range of 0.1 -41 l/kg. Transformation of the Vd data to a logarithmic scale leads to a normal distribution with skewness of 0.005.
QSAR model for Vd
The stepwise regression analyses for Vd resulted in the following equation:
log Vd = -0.151(±0.13) +0.364 (±0.038) log P -0.260 (±0.039) log D 1 -0.086 (±0.027) µ MM (9) n = 70 s = 0.390 r = 0.787 F = 35.7 p = 0.000 Equation (9) indicates that there is a correlation between partition coefficient and Vd, but the overall relationship is improved by the introduction of other computed parameters. The distribution coefficient at pH=1 (log D 1 ) has a negative effect on Vd.
The distribution coefficient at this extreme pH value represents a different feature of the molecules than hydrophobicity alone. At pH 1, acids are completely in their un-ionised form and bases are fully protonated, thus acids will have a log D 1 value close to their log P whereas for bases, log D 1 will be much lower than the true log P. In other words, log D 1 is higher (and therefore, according to equation 9, Vd is lower) for compounds which are less ionised at this acidic pH; these are either acidic drugs or drugs with lower basicities. It should be noted that the variables in the equation are not strongly correlated with each other, and the highest correlation being between log D 1 and log P with r = 0.488. Log P, log D 1 and µ MM used in equation (9), as well as log D 7.4 , are listed in Table 1 .
QSAR for Unbound Vd
A common approach to model the volume of distribution is to correct for plasma protein binding and derive QSARs for the unbound (intrinsic) volumes (Ritschel & Hammer 1980; Blakey et al 1997) . The fraction of protein-bound drug in plasma, ppb, was collected from the literature (see Table 1 ). The unbound volume of distribution was calculated by dividing Vd by the fraction of non-protein-bound drug in plasma.
Stepwise regression analysis on the unbound volume of distribution (volume of distribution of free drug, Vdu) resulted in equation (10). The ppb values of four drugs in Table 1 were not found in the literature and they were omitted from the regression analysis: 
QSARs for acidic drugs
Based on the fiA and fiB values (Table 3) , acidic drugs were identified as described in the methods. There were 27 such drugs in this group. The following equations resulted from the stepwise regression analysis on log Vd and log Vdu: Note: there were 2 missing ppb values for acidic drugs.
In equation (11) and (12), Q -is the lowest atomic charge in the molecule, MW/V is molecular weight divided by the volume of molecule (density), 3 χ p is the third order path molecular connectivity index, and S(I) is the highest electrotopological state index in the molecule.
The importance of lipophilicity in the distribution process is expressed by the presence of the distribution coefficient at pH 7.4 in equation (11) and the partition coefficient in equation (12). In equation (11) the lowest atomic charge in the molecule has a negative sign, which shows that the presence of a heteroatom with higher electronegativity is favoured. Bearing in mind the significance of the lipophilicity parameter, this suggests that an electronegative heteroatom without a free hydrogen atom (non-hydrogen-bond donor) will increase Vd. The third parameter in equation (11) is the density of molecules meaning that the presence of heavy atoms (bromine, chlorine, oxygen and nitrogen atoms) increases log Vd.
The second parameter in equation (12) Table 3 shows the values of Q -, MW/V, 3 χ p and S(I) for all the drugs.
QSARs for basic drugs
The following equations were obtained for the basic drugs in the dataset: where log (fu calc /pK a ) is the logarithm of the percent of drug unionised at pH 7.4 divided by the pK a of the bases. The inclusion of the distribution coefficient at pH 7.4 and µ MM in equation (13) is analogous to equations (9) and (11).
Two new parameters are included in the QSAR for the apparent volume of distribution of free drug (note that there are two missing ppb data for basic drugs): Table 3 . Table 4 shows the equations obtained for the training set based on equations (9-14). The
Validation of the QSAR models
Vd values predicted for the test sets using the equations for the training sets (equations (15-20) ) are tabulated in Table 5 for all drugs, acidic drugs and basic drugs. The goodness of prediction has been presented by mean fold error and prediction accuracy, i.e. fraction of compounds predicted to have a Vd value within a 2-fold error from the experimental value.
Discussion
The distribution of a compound in the human body is a function of its affinity to various To investigate the effect of protein binding correction in the present study, the unbound volume of distribution, Vdu, has been compared to Vd for the development of QSARs.
Comparison of equations (10), (12) and (14) with equations (9), (11) and (13) shows that QSARs for unbound Vd provide statistically better models with higher r and F values. However, predictive ability, as tested by the mean fold errors for the test sets, does not reflect this statistical superiority (Figure 1 ). This could be due to the fact that the parameters in equations (10), (12) and (14) 
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The contribution of each term in equation (21) to the relationship with the unbound Vd (equation (10)) was examined by regressing log Vd and log 1/(1-ppb) against the structural descriptors in equation (10). The results (equations (22) and (23)) show that while log P is a significant descriptor of both Vd and protein binding, C arom is describing protein binding only. Note that in equation ( 
Similar conclusions can be drawn from the corresponding equations obtained for acids and bases, where, using the example of the acids, none of the parameters of equation (12) were statistically correlated to log Vd (results not presented).
All the QSARs obtained in this study include either a partition, or a distribution, coefficient parameter. This is consistent with many previously published reports that high lipophilicity is associated with large Vd ( Van der Graaf et al 1999; Ritschel & Hammer, 1980; Van de Waterbeemed et al 2001) . Although the experimental log P and log D 7.4 parameters had also been used in the stepwise regression analysis, only the ACD calculated parameters appeared in the QSARs. There was generally good agreement between log P* and the ACD calculated log P (r = 0.881). The correlation between ACD calculated log D 7.4 and log D 7.4calc (calculated from experimental pK a and log P*) was not as good (r = 0.709). This is probably due to the deviations of calculated pK a as well as log P, from the experimental values. For example, one significant outlier from the correlation, glutethimide, is an acid with a pK a(Exp) value of 4.52 and an ACD calculated pK a of 11.36. The most important feature of equation (9) is that it shows a higher volume of distribution for basic drugs compared with the acids (note the negative coefficient of the log D 1 parameter). This could be due partly to the high protein binding of most acidic drugs. Karalis et al (2002) observed that in a class of compounds with higher volume of distribution, the acid/base ratio was lower, whereas protein-binding extent was highest in the class with lowest volume of distribution. In equation (11) for basic drugs, the inclusion of log(fu calc /pK a ) shows that drugs with a higher cationic fraction have a higher volume of distribution. In addition, Figure 2 reveals that log fu calc increases with increase in log (fu calc /pK a ) values, and reaches a maximum where it remains almost constant with increasing log (fu calc /pK a ) values. The maximum corresponds to compounds with low pK a values, where fu calc does not reflect changes in pK a . For example fu calc values remain constant at 100.00 for pK a ranges of 0.5 -2.4 (see Table 3 ). According to equation (13), the stronger the basicity of a drug, i.e. a lower percentage in the unionised form and high pK a values, the higher apparent volume of distribution it will maintain; this is not due merely to the higher ionisation but also due to the electron directing properties of the rest of the molecule (substituents) on the basic nitrogen atom of the molecule.
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According to Figure 1 , the mean fold errors of prediction from the QSAR for log Vd show some decrease when the drugs are separated into acidic and basic groups. The similar mean fold errors of prediction could be due to the fact that the number of chemicals is lower in the acidic and basic drugs sets. This was explored further by splitting the datasets in a 4:1 ratio of training to test sets. Mean fold errors of prediction using equations 11-14 (separate equations for acids and bases) were decreased to 1.44, 1.55, 1.73 and 2.06 respectively. On the other hand, the new splitting process did not change the prediction errors of equations 9 and 10 significantly. Therefore, the results suggest the use of models 11 and 13 for prediction purposes. This will require a knowledge of experimental pK a values as well as the calculated parameters of these equations. On the other hand, apparent volume of distribution of all drugs could be predicted using equation (9), with lower accuracy, without the need of any experimental measurement including pK a and the extent of protein binding. Prediction via equation
(9) has a mean fold error of 2.03. A similar mean fold error has been reported in a previous study, where only basic and neutral drugs were studied and the ratio of the number of compounds in the test series to those in the training set was 14:50 (Lombardo et al 2002) . In comparison with the error normally associated with the prediction using the interspecies scaling, which is reported to be ranging from 1.56 to 2.78 (Obach et al 1997), our mean fold error is encouraging. To confirm this point further, the mean fold error for the Vd predictions of a study based on extrapolation from animals to man (Mahmood 1998) was calculated to be 1.82.
In Table 5 
Conclusions
Statistically significant QSARs were constructed for the volume of distribution of a group of drugs as a whole and when separated into acids and bases. Unbound volume of distribution was also investigated as a possible QSAR target. Comparing the different QSARs, it was concluded that although correction of Vd for protein binding improved the statistical fit, it lessened the predictive power of the QSAR. This investigation presented a predictive model for the prediction of volume of distribution without a need for experimental measurements (equation (9)). Also, a more accurate prediction is possible using equations 11 and 13 for acids and bases, but this will require the experimental pK a as well as calculated parameters. The mean fold error associated with the prediction using equations 9 is approximately 2, which is within the range of mean fold errors of prediction using the extrapolation methods from animal species. 5 χ ch and 6 χ ch ), the highest atomic electrotopological index (S(I)), molecular shape indexes ( 0 κ -3 κ and 0 κ a -3 κ a ), and delta connectivity indexes (X0 -X3) ACD/LOGD Calculated partition coefficient (log P), calculated distribution coefficient at pH 7.4 and 1 (log D 7.4 and log D 1 ), calculated pK a (pK a ), the fraction unionised at pH 7.4 (fu), polarisability (α), molecular volume (V), molar refractivity (MR) and parachor (PA)
Experimental parameters
Experimental pK a obtained from the literature ((pK a(Exp) ), see Table 3 for the references); log P obtained from the Biobyte database star list (log P*); log D 7.4calc is log D calculated using pK a(Exp) and log P values at pH 7.4; fiB, fiA and fu calc are, respectively, cationic, anionic and unionised percents at pH=7.4 calculated using pK a(Exp) values
Other parameters
The total number of oxygen and nitrogen atoms (N N+O ), number of hydrogen atoms connected to oxygen or nitrogen (N H ), number of double bonds (N = ), number of rotatable bonds (N rotat ), total number of bonds (N bond ), number of aromatic carbon atoms (C arom ), number of aliphatic carbon atoms (C alip ), logarithms of molecular surface area and weight (log SA and log MW), logarithm of the unionised fraction at pH=7.4 divided by the experimental pK a (log(fu calc /pK a(Exp) )), molecular volume divided by the length (V/l) and molecular weight divided by the volume (MW/V) 
